College of Al-Nahrain University starts for the clinical examination of a new medicine for treatment of corna complications in cooperation with Ministry of Health in February/2020.The team of Al-Nahrain University involves ,the dean of College of Pharamcy,Asst.Prof.Dr.Hayder Bahah ,Asst.Prof.Dr.Rafel Shakeeb /an instructor in College of Pharamcy and Inst.Dr.Aummer Abd Al-KAthem ,an instructor in Biotechnology Researches Centre.
The treatment by Chinese Wuhan Hospital aims for achieving techniques and means of treatment of the virus complications. Cytokine storm whose structure comprises three components simply and one intends to publish research papers and record as a patent after the end of clinical examination.
After the end of laboratory research,it has been directed to make a medicine for donation of Al-Nharian University by the professional pharmacist for making the medicine of the Italian Companies ,then send this medicine to Al-Shafaa Hospital after it enters Iraq.
Moreover,this medicine prevents patients to be setting critical illness and decrease the clots which threaten the life of patient .This medicine will be available to all after the clinical examination and recording as a patent in Al-Nhrain University and manufacturer which lessen the hospitalization of patient and this represent as an important role of Al-Nharian University in society.
Translated by
Prof.Aula Abdul Ghaffour Muhammad Salah